🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The study was to evaluate the safety and and immune response of each of thr...
Status
Completed
Location
NZOZ Bioscience Sp zoo
Start Date
2011-09
Trial ID
NCT01434680
Treatments Being Tested
This study is to confirm non-inferiority of the three MenACWY vaccines (Men...
Status
Completed
Location
Children's Hospital Research Institute, University of Calgary
Start Date
2018-09-20
Trial ID
NCT03694405
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-06
Trial ID
NCT01506193
Treatments Being Tested
In the UK, infants currently receive a 5-in-1 vaccine (Pediacel) at 2, 3 an...
Status
Completed
Location
St George's Vaccien Institute
Start Date
2013-07
Trial ID
NCT01896596
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of the study is to evaluate the immune response of toddlers, to...
Status
Completed
Location
Universidad Rey Juan Carlos I
Start Date
2007-01
Trial ID
NCT00392808
Treatments Being Tested
Dosage-Escalation Study to Evaluate the Safety and Immunogenicity of an Alu...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-01
Trial ID
NCT02639351
Treatments Being Tested
The primary purpose of this study is to evaluate the persistence of bacteri...
Status
Completed
Location
Dr. Johannes Kandzora and Dr. Kathrin Kandzora
Start Date
2011-05
Trial ID
NCT01345721
Treatments Being Tested
To assess the immunogenicity of Novartis (formerly Chiron) Meningococcal AC...
Status
Completed
Location
Children's Hospital of Eastern Ontario Research Institute
Start Date
2005-06
Trial ID
NCT00310856
Treatments Being Tested